{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:49:06Z","timestamp":1792676946412,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013323","name":"Yancheng Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["YCBE202532"],"award-info":[{"award-number":["YCBE202532"]}],"id":[{"id":"10.13039\/501100013323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"publisher","award":["YK2024150"],"award-info":[{"award-number":["YK2024150"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.brainresbull.2025.111595","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:31:44Z","timestamp":1761183104000},"page":"111595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Esketamine relieves depressive-like behaviors in MPTP-induced Parkinson disease mice via GPR109A-dependent reduction of neuroinflammation"],"prefix":"10.1016","volume":"232","author":[{"given":"Shu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2025.111595_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101840","article-title":"Neurobiology of depression in parkinson's disease: insights into epidemiology, molecular mechanisms and treatment strategies","volume":"85","author":"Ahmad","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111595_bib2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1503\/jpn.160175","article-title":"Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism","volume":"42","author":"Aleksandrova","year":"2017","journal-title":"J. Psychiatry Neurosci."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111595_bib3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1096\/fj.201801033R","article-title":"Ketones and pain: unexplored role of hydroxyl carboxylic acid receptor type 2 in the pathophysiology of neuropathic pain","volume":"33","author":"Boccella","year":"2019","journal-title":"Faseb J."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111595_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13040634","article-title":"Microglia and astrocytes dysfunction and key Neuroinflammation-Based biomarkers in parkinson's disease","volume":"13","author":"Chen","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.brainresbull.2025.111595_bib5","article-title":"Effects of esketamine and fluoxetine on depression-like behaviors in chronic variable stress: a role of plasma inflammatory factors","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111595_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-019-05346-5","article-title":"MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling","volume":"237","author":"Fujita","year":"2020","journal-title":"Psychopharmacology"},{"issue":"22","key":"10.1016\/j.brainresbull.2025.111595_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221834","article-title":"The yin and yang of Microglia-Derived extracellular vesicles in CNS injury and diseases","volume":"13","author":"Ghosh","year":"2024","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.brainresbull.2025.111595_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184559","article-title":"Niacin ameliorates Neuro-Inflammation in parkinson\u2019s disease via GPR109A","volume":"20","author":"Giri","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainresbull.2025.111595_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/978-981-19-7376-5_21","article-title":"The glutamatergic system in Treatment-Resistant depression and comparative effectiveness of ketamine and esketamine: role of inflammation?","volume":"1411","author":"Halaris","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.brainresbull.2025.111595_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094674","article-title":"The neuroprotective effects of GPR4 inhibition through the attenuation of caspase mediated apoptotic cell death in an MPTP induced mouse model of parkinson's disease","volume":"22","author":"Haque","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111595_bib11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40263-021-00816-x","article-title":"Novel glutamatergic modulators for the treatment of mood disorders: current status","volume":"35","author":"Henter","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.brainresbull.2025.111595_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110583","article-title":"Niacin mitigates blood-brain barrier tight junctional proteins dysregulation and cerebral inflammation in ketamine rat model of psychosis: role of GPR109A receptor","volume":"119","author":"Ibrahim","year":"2022","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111595_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14473","article-title":"Neuroprotective effects of gemfibrozil in neurological disorders: focus on inflammation and molecular mechanisms","volume":"30","author":"Ivraghi","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111595_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.brainresbull.2025.111595_bib15","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00702-022-02559-5","article-title":"The pathobiological basis of depression in parkinson disease: challenges and outlooks","volume":"129","author":"Jellinger","year":"2022","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111595_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1903305","article-title":"Esketamine for treatment-resistant depression - first FDA-Approved antidepressant in a new class","volume":"381","author":"Kim","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.brainresbull.2025.111595_bib17","article-title":"Botulinum neurotoxin a ameliorates depressive-like behavior in a reserpine-induced parkinson's disease mouse model via suppressing hippocampal microglial engulfment and neuroinflammation","volume":"44","author":"Li","year":"2023","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.brainresbull.2025.111595_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115154","article-title":"Blockade of mGluR1 and mGluR5 in the lateral habenula produces the opposite effects in the regulation of depressive-like behaviors in the hemiparkinsonian rats","volume":"386","author":"Liu","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2025.111595_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuroscience.2024.12.062","article-title":"Esketamine alleviates LPS-induced depression-like behavior by activating Nrf2-mediated anti-inflammatory response in adolescent mice","volume":"567","author":"Ma","year":"2025","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111595_bib20","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s10787-022-01043-6","article-title":"Metformin improves depressive-like behavior in experimental parkinson's disease by inducing autophagy in the substantia nigra and hippocampus","volume":"30","author":"Mendon\u00e7a","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.brainresbull.2025.111595_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2024.110212","article-title":"A deep-learning-based threshold-free method for automated analysis of rodent behavior in the forced swim test and tail suspension test","volume":"409","author":"Meng","year":"2024","journal-title":"J. Neurosci. Methods"},{"issue":"7","key":"10.1016\/j.brainresbull.2025.111595_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/phar.2707","article-title":"Safety and effectiveness of NMDA receptor antagonists for depression: a multidisciplinary review","volume":"42","author":"Moore","year":"2022","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111595_bib23","first-page":"3126","article-title":"Neuropeptide-S affects cognitive impairment and depression-like behavior on MPTP induced experimental mouse model of Parkinson\u2019s disease","volume":"51","author":"\u00d6zkan","year":"2021","journal-title":"Turk. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111595_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41531-023-00449-5","article-title":"A systematic review and meta-analysis of inflammatory biomarkers in parkinson's disease","volume":"9","author":"Qu","year":"2023","journal-title":"NPJ Park. Dis."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111595_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27485","article-title":"Association of caregiver depression risk with patient outcomes in parkinson disease","volume":"6","author":"Rashid","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111595_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci15010041","article-title":"Eugenia uniflora effects on the Depressive-like behavior of MPTP-Exposed female rats: apoptosis and \u03b1-Synuclein modulation","volume":"15","author":"Savall","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.brainresbull.2025.111595_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1464706","article-title":"Behavioral analysis of motor and non-motor impairment in rodent models of parkinson's disease","volume":"16","author":"Sheta","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111595_bib28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/02698811221084055","article-title":"The antidepressant effect and safety of non-intranasal esketamine: a systematic review","volume":"36","author":"Smith-Apeldoorn","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2025.111595_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156490","article-title":"Sea buckthorn berries alleviate ulcerative colitis via regulating gut faecalibaculum rodentium-mediated butyrate biosynthesis","volume":"139","author":"Song","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.brainresbull.2025.111595_bib30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","article-title":"Probiotic clostridium butyricum ameliorated motor deficits in a mouse model of parkinson's disease via gut microbiota-GLP-1 pathway","volume":"91","author":"Sun","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111595_bib31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4103\/1673-5374.354514","article-title":"Emerging roles of GPR109A in regulation of neuroinflammation in neurological diseases and pain","volume":"18","author":"Taing","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.brainresbull.2025.111595_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105666","article-title":"The need for guidance in antidepressant drug development: revisiting the role of the forced swim test and tail suspension test","volume":"151","author":"Trunnell","year":"2024","journal-title":"Regul. Toxicol. Pharm."},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111595_bib33","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/glia.24130","article-title":"Activation of microglial GPR109A alleviates thermal hyperalgesia in female lupus mice by suppressing IL-18 and glutamatergic synaptic activity","volume":"70","author":"Viatchenko-Karpinski","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.brainresbull.2025.111595_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122004","article-title":"Niacin modulates depressive-like behavior in experimental colitis through GPR109A-dependent mechanisms","volume":"330","author":"Wadie","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111595_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2025.111595_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114308","article-title":"Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis","volume":"160","author":"Wei","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"10","key":"10.1016\/j.brainresbull.2025.111595_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102519","article-title":"Neurobiological basis of increased risk for suicidal behaviour","volume":"10","author":"Wis\u0142owska-Stanek","year":"2021","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.brainresbull.2025.111595_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/nu14194163","article-title":"Neuroprotective effects of sodium butyrate and monomethyl fumarate treatment through GPR109A modulation and intestinal barrier restoration on PD mice","volume":"14","author":"Xu","year":"2022","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.brainresbull.2025.111595_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12975-016-0496-0","article-title":"Dimethyl fumarate and monomethyl fumarate promote Post-Ischemic recovery in mice","volume":"7","author":"Yao","year":"2016","journal-title":"Transl. Stroke Res."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111595_bib40","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s10753-024-02139-7","article-title":"The neuroprotective effects of agmatine on parkinson's disease: focus on oxidative stress, inflammation and molecular mechanisms","volume":"48","author":"Zamanian","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.brainresbull.2025.111595_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9860855","article-title":"Neuroprotective and Anti-inflammatory effects of pioglitazone on traumatic brain injury","volume":"2022","author":"Zamanian","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.brainresbull.2025.111595_bib42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jad.2023.08.053","article-title":"Association between niacin intake and depression: a nationwide cross-sectional study","volume":"340","author":"Zhao","year":"2023","journal-title":"J. Affect Disord."},{"issue":"183","key":"10.1016\/j.brainresbull.2025.111595_bib43","doi-asserted-by":"crossref","first-page":"714","DOI":"10.24976\/Discov.Med.202436183.67","article-title":"Analgesic mechanism of dexmedetomidine and esketamine in rats with spinal cord injury","volume":"36","author":"Zhao","year":"2024","journal-title":"Discov. Med."},{"key":"10.1016\/j.brainresbull.2025.111595_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114782","article-title":"Low-dose esketamine suppresses NLRP3-mediated apoptotic and pyroptotic cell death in microglial cells to ameliorate LPS-induced depression via ablating GSK-3\u03b2","volume":"459","author":"Zhou","year":"2024","journal-title":"Behav. Brain Res."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923025004071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923025004071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:27:11Z","timestamp":1778934431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923025004071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"alternative-id":["S0361923025004071"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111595","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esketamine relieves depressive-like behaviors in MPTP-induced Parkinson disease mice via GPR109A-dependent reduction of neuroinflammation","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111595"}}